Clinical Trial Details
| Trial ID: | L3788 |
| Source ID: | NCT04970940 |
| Associated Drug: | Treatment A |
| Title: | The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2 |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | T2DM (Type 2 Diabetes Mellitus) |
| Interventions: | DRUG: Treatment A|DRUG: Treatment B|DRUG: Treatment C |
| Outcome Measures: | Primary: AUCĪ of AJU-A51R1 and AJU-A51R2, Area Under Curve tau, predose, 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 12, 24 hours post-dose|Css,max of AJU-A51R1 and AJU-A51R2, Cmax, steady state, predose, 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 12, 24 hours post-dose | |
| Sponsor/Collaborators: | Sponsor: AJU Pharm Co., Ltd. |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE1 |
| Enrollment: | 30 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2020-07-02 |
| Completion Date: | 2020-12-31 |
| Results First Posted: | |
| Last Update Posted: | 2021-07-21 |
| Locations: | Min-gul Kim, Jeonju, Korea, Korea, Republic of |
| URL: | https://clinicaltrials.gov/show/NCT04970940 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|